Skip header and navigation

Refine By

   MORE

21 records – page 1 of 3.

The acceptance of the cervical cytology screening programme in the province of British Columbia.

https://arctichealth.org/en/permalink/ahliterature111163
Source
J Obstet Gynaecol Br Commonw. 1967 Aug;74(4):479-86
Publication Type
Article
Date
Aug-1967

Adenocarcinoma of the fallopian tube. Experience with 41 patients.

https://arctichealth.org/en/permalink/ahliterature249383
Source
Obstet Gynecol. 1977 Dec;50(6):654-7
Publication Type
Article
Date
Dec-1977
Author
J L Benedet
G W White
R N Fairey
D A Boyes
Source
Obstet Gynecol. 1977 Dec;50(6):654-7
Date
Dec-1977
Language
English
Publication Type
Article
Keywords
Adenocarcinoma - diagnosis - drug therapy - mortality - pathology - radiotherapy
Adult
Aged
Antineoplastic Agents - therapeutic use
British Columbia
Dilatation and Curettage
Fallopian Tube Neoplasms - diagnosis - drug therapy - mortality - pathology - radiotherapy
Female
Humans
Middle Aged
Neoplasm Staging
Phosphorus Radioisotopes - therapeutic use
Radiotherapy, High-Energy
Abstract
Forty-one cases of primary fallopian tube carcinoma treated at our institution over the years 1946 to 1976 are described. The overall 5-year survival rate was 34.4%, although patients with early tumors had a 72.7% survival rate. The single most important factor affecting survival appeared to be the extent of disease at the time of diagnosis. Past and present treatment modalities are discussed, and proposals for management of this disease are outlined.
PubMed ID
412144 View in PubMed
Less detail

The British Columbia screening program.

https://arctichealth.org/en/permalink/ahliterature109999
Source
Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):1005-11
Publication Type
Article
Date
Jul-1969

A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix.

https://arctichealth.org/en/permalink/ahliterature255389
Source
J Obstet Gynaecol Br Commonw. 1972 Aug;79(8):673-9
Publication Type
Article
Date
Aug-1972

Cervical cancer detection in British Columbia. A progress report.

https://arctichealth.org/en/permalink/ahliterature110696
Source
J Obstet Gynaecol Br Commonw. 1968 Apr;75(4):392-404
Publication Type
Article
Date
Apr-1968

Cervical intraepithelial neoplasia in female prisoners in British Columbia.

https://arctichealth.org/en/permalink/ahliterature232329
Source
CMAJ. 1988 Oct 15;139(8):733-6
Publication Type
Article
Date
Oct-15-1988
Author
H. Karsai
A J Coldman
D. Gavin
S. Brumelle
D A Boyes
G H Anderson
J L Benedet
Author Affiliation
Cancer Control Agency of British Columbia, Vancouver.
Source
CMAJ. 1988 Oct 15;139(8):733-6
Date
Oct-15-1988
Language
English
Publication Type
Article
Keywords
Adult
Aged
British Columbia
Female
Humans
Mass Screening
Middle Aged
Papanicolaou test
Precancerous Conditions - epidemiology - prevention & control
Prisoners
Risk factors
Uterine Cervical Neoplasms - epidemiology
Vaginal Smears
Abstract
The annual incidence rates of cervical intraepithelial neoplasia (CIN), grades I to III, from 1975 to 1983 among 2440 prisoners in British Columbia for whom a history of screening by means of the Papanicolaou test was available were two to three times higher than the expected rates in the general female population of British Columbia. The rates among the prisoners from 1970 to 1984, although small, increased with a trend similar to that in the general population. Despite increases in the general population we conclude that prisoners are still at high risk for CIN.
Notes
Cites: Am J Obstet Gynecol. 1968 Mar 1;100(5):607-145638481
Cites: Br J Vener Dis. 1968 Sep;44(3):254-55687050
Cites: Clin Invest Med. 1982;5(1):1-297116711
Cites: Acta Obstet Gynecol Scand. 1982;61(3):199-2037124352
Cites: Int J Epidemiol. 1985 Dec;14(4):521-74086138
PubMed ID
3167733 View in PubMed
Less detail

Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens.

https://arctichealth.org/en/permalink/ahliterature245389
Source
Gynecol Oncol. 1980 Oct;10(2):173-87
Publication Type
Article
Date
Oct-1980

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

https://arctichealth.org/en/permalink/ahliterature245460
Source
Can Med Assoc J. 1980 Sep 6;123(5):365-71
Publication Type
Article
Date
Sep-6-1980
Author
A B Miller
D J Klaassen
D A Boyes
D J Dodds
A. Gerulath
M E Kirk
M. Levitt
J G Pearson
C. Wall
Source
Can Med Assoc J. 1980 Sep 6;123(5):365-71
Date
Sep-6-1980
Language
English
Publication Type
Article
Keywords
Adult
Aged
Antineoplastic Agents - administration & dosage
Canada
Carcinoma - drug therapy
Clinical Trials as Topic
Drug Administration Schedule
Drug Therapy, Combination
Female
Fluorouracil - administration & dosage
Humans
Melphalan - administration & dosage
Methotrexate - administration & dosage
Middle Aged
Ovarian Neoplasms - drug therapy
Abstract
The results of a national clinical trial to compare combination and sequential chemotherapy for stage III or IV ovarian cancer are reported. Of the 253 patients from 16 centres across Canada who were admitted to the trial 13 were excluded from the analysis. All the patients were observed for 2 to 5 years from entry into the trial. There were no differences in response to therapy or in survival between the patients treated with melphalan followed by 5-fluorouracil and then by methotrexate in high dosage and the patients treated with the same agents in combination. Patients with minimal residual disease after resection of stage III ovarian cancer had a good prognosis. Other favourable prognostic factors were age (less than 55 years), performance status (90% or 100% on the Karnofsky scale) and histologic grade of the tumour.
Notes
Cites: Am J Obstet Gynecol. 1965 Dec 15;93(8):1102-115892067
Cites: Am J Obstet Gynecol. 1965 Dec 15;93(8):1112-215847906
Cites: Int Surg. 1967 Apr;47(4):398-4014962186
Cites: Surg Gynecol Obstet. 1967 Oct;125(4):819-246041727
Cites: Cancer. 1968 Mar;21(3):508-135637955
Cites: J Mt Sinai Hosp N Y. 1968 Jan-Feb;35(1):52-674966488
Cites: Am J Obstet Gynecol. 1968 Apr;100(7):1012-75644296
Cites: Can Med Assoc J. 1968 Mar 16;98(11):539-415647240
Cites: Obstet Gynecol. 1970 Feb;35(2):278-864189962
Cites: Am J Obstet Gynecol. 1970 Jul 1;107(5):691-7034316665
Cites: Am J Obstet Gynecol. 1970 Nov 15;108(6):878-884098756
Cites: Cancer. 1971 Jun;27(6):1302-55088208
Cites: Cancer Res. 1973 Jul;33(7):1729-344541737
Cites: Cancer. 1976 Jul;38(1):388-94947531
Cites: Br J Cancer. 1977 Jan;35(1):1-39831755
Cites: N Engl J Med. 1978 Dec 7;299(23):1261-6101843
Cites: Cancer Treat Rep. 1979 Feb;63(2):249-54109198
Cites: Cancer Treat Rep. 1979 Feb;63(2):281-8376134
Cites: Cancer Treat Rep. 1979 Feb;63(2):289-95376135
Cites: Cancer Treat Rep. 1979 Feb;63(2):297-9376136
Cites: Cancer Treat Rep. 1979 Feb;63(2):311-7109202
Cites: Obstet Gynecol. 1965 Apr;25:475-814268035
Cites: JAMA. 1962 Jul 28;181:295-913861733
PubMed ID
7020903 View in PubMed
Less detail

21 records – page 1 of 3.